Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Yogev

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|June 15, 2011
Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patientsJennifer R King, Ram Yogev, Patrick Jean-Philippe, et al.
International Journal of Antimicrobial Agents|October 24, 2008
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infectionAdriano Arguedas, Jaime Cespedes, Francesc Aseni Botet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2004
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infectionWalter T Hughes, Wayne M Dankner, Ram Yogev, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
AIDS (London, England)|May 5, 2012
Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of ageDeborah Persaud, Paul E Palumbo, Carrie Ziemniak, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patientsJennifer R King, Edward P Acosta, Ellen Chadwick, et al.
The Pediatric Infectious Disease Journal|October 2, 2003
Linezolid for the treatment of complicated skin and skin structure infections in childrenRam Yogev, Lori E Patterson, Sheldon L Kaplan, et al.
The Pediatric Infectious Disease Journal|August 13, 2003
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenSheldon L Kaplan, Jaime G Deville, Ram Yogev, et al.
Vaccine|May 13, 2008
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremiaWilliam Borkowsky, Ram Yogev, Petronella Muresan, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|June 15, 2011
Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patientsJennifer R King, Ram Yogev, Patrick Jean-Philippe, et al.
International Journal of Antimicrobial Agents|October 24, 2008
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infectionAdriano Arguedas, Jaime Cespedes, Francesc Aseni Botet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2004
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infectionWalter T Hughes, Wayne M Dankner, Ram Yogev, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
AIDS (London, England)|May 5, 2012
Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of ageDeborah Persaud, Paul E Palumbo, Carrie Ziemniak, et al.
The Pediatric Infectious Disease Journal|March 14, 2003
Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patientsJennifer R King, Edward P Acosta, Ellen Chadwick, et al.
The Pediatric Infectious Disease Journal|October 2, 2003
Linezolid for the treatment of complicated skin and skin structure infections in childrenRam Yogev, Lori E Patterson, Sheldon L Kaplan, et al.
The Pediatric Infectious Disease Journal|August 13, 2003
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenSheldon L Kaplan, Jaime G Deville, Ram Yogev, et al.
Vaccine|May 13, 2008
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremiaWilliam Borkowsky, Ram Yogev, Petronella Muresan, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Pageof 13